The U.S. Department of Defense's Medical Supply Chain (DLA Troop Support Medical) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of the prescription medication XALKORI 250 MG CAPSULE 60S. The $12,877.79 firm-fixed-price contract has a completion date of July 31, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $12,865.21 firm-fixed-price contract is for the supply of XALKORI 200 MG CAPSULE 60S, a pharmaceutical product, to support federal healthcare programs. The contract does not have a set-aside designation and has an ultimate completion date of September 24, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,549,264 units of the pharmaceutical product XALKORI 250 MG CAPSULE 60S. The contract has a completion date of February 27, 2024 and a potential value of $12,877.79. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp,...
This federal contract award, valued at $12,865.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of XALKORI 200 MG CAPSULE 60S, a pharmaceutical product, with a performance period through December 6, 2024. The contract is not designated as a set-aside and represents an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award, valued at $12,679.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XALKORI 250 MG CAPSULE 60S, a pharmaceutical product. This award is not associated with a set-aside program and was made through full and open competition. The prime contractor, AmerisourceBergen Drug Corp, is a subsidiary of Cencora, Inc., a larger pharmaceutical distribution company. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of various pharmaceutical products and medical supplies. The contract has a ceiling value of $17,040.18 and a period of performance through August 1, 2024. AmerisourceBergen is an experienced federal contractor, holding several Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice, valued up to...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $37,582.44 and an ultimate completion date of November 18, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation, for the provision of various pharmaceutical products and medical supplies to support military healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $12,884.40, is for the delivery of pharmaceutical products and medical supplies to support military treatment programs and facilities. This is a firm fixed price delivery order contract, and no set-aside designation was used....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of pharmaceutical products. The contract has a ceiling value of $31,245.37 and is a firm fixed price delivery order with no set-aside designation. The award date is September 24, 2024, and the ultimate completion date is September 25, 2024. AmerisourceBergen Drug Corporation is a major pharmaceutical distributor that provides a wide range of prescription medications,...
This is a $1,121.94 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is not set aside and has an ultimate completion date of April 16, 2024. Amerisourcebergen, as a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is fulfilling this order through its Corporate Office division. The company holds an Indefinite Delivery Contract (IDC)...